Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
4.780
+0.150 (3.24%)
Dec 20, 2024, 4:00 PM EST - Market closed
Vanda Pharmaceuticals Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$15.50
Upside
+224.27%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +276.57% | Oct 31, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $11 → $13 | Buy | Maintains | $11 → $13 | +171.97% | Aug 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $11 | Buy | Initiates | $11 | +130.13% | Jul 11, 2024 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $24 → $12 | Strong Buy → Hold | Downgrades | $24 → $12 | +151.05% | Feb 25, 2022 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $14 | Strong Buy → Hold | Downgrades | $14 | +192.89% | Jan 14, 2021 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $14 | Hold → Strong Buy | Upgrades | $14 | +192.89% | Oct 29, 2020 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $14 | Strong Buy → Hold | Downgrades | $14 | +192.89% | Jun 9, 2020 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $14 | Hold → Strong Buy | Upgrades | $14 | +192.89% | Mar 12, 2020 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $19 | Hold → Strong Buy | Upgrades | $19 | +297.49% | Aug 1, 2019 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Feb 6, 2019 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades $29 | Buy → Hold | Downgrades | $29 | +506.69% | Dec 11, 2018 |
| Citigroup | Citigroup | Strong Buy Maintains $31 → $47 | Strong Buy | Maintains | $31 → $47 | +883.26% | Dec 7, 2018 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold → Buy Upgrades $43 | Hold → Buy | Upgrades | $43 | +799.58% | Dec 4, 2018 |
| Jefferies | Jefferies | Strong Buy Initiates $26 | Strong Buy | Initiates | $26 | +443.93% | Nov 8, 2018 |
| Citigroup | Citigroup | Strong Buy Maintains $27 → $31 | Strong Buy | Maintains | $27 → $31 | +548.54% | Oct 16, 2018 |
| Oppenheimer | Oppenheimer | Buy Maintains $27 → $29 | Buy | Maintains | $27 → $29 | +506.69% | Sep 21, 2018 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.